Calvenza™ EHV is equine rhinopneumonitis vaccine killed virus vaccine. For the vaccination of healthy, susceptible horses 6 months of age or older, including pregnant mares, as an aid in the reduction of respiratory disease due to equine herpesvirus type 1 (EHV-1) and type 4 (EHV-4).
Benefits:
- Proven safe
- Minimal vaccine site reactions
- Three dose regiment conforms to AAEP recommendations
- Flexible dose administration